[go: up one dir, main page]

AT275037B - Process for the manufacture of agents for inhibiting immune reactions - Google Patents

Process for the manufacture of agents for inhibiting immune reactions

Info

Publication number
AT275037B
AT275037B AT926367A AT926367A AT275037B AT 275037 B AT275037 B AT 275037B AT 926367 A AT926367 A AT 926367A AT 926367 A AT926367 A AT 926367A AT 275037 B AT275037 B AT 275037B
Authority
AT
Austria
Prior art keywords
agents
manufacture
immune reactions
inhibiting immune
inhibiting
Prior art date
Application number
AT926367A
Other languages
German (de)
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Application granted granted Critical
Publication of AT275037B publication Critical patent/AT275037B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT926367A 1966-10-12 1967-10-12 Process for the manufacture of agents for inhibiting immune reactions AT275037B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB45695/66A GB1136039A (en) 1966-10-12 1966-10-12 Improvements relating to immunosuppressive agents

Publications (1)

Publication Number Publication Date
AT275037B true AT275037B (en) 1969-10-10

Family

ID=10438194

Family Applications (1)

Application Number Title Priority Date Filing Date
AT926367A AT275037B (en) 1966-10-12 1967-10-12 Process for the manufacture of agents for inhibiting immune reactions

Country Status (6)

Country Link
AT (1) AT275037B (en)
BE (1) BE705035A (en)
ES (1) ES345979A1 (en)
FR (2) FR1552939A (en)
GB (1) GB1136039A (en)
NL (1) NL6713800A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4043869A (en) 1972-07-13 1977-08-23 Koch-Light Laboratories, Ltd. Water insoluble biologically active material
ES2759252T3 (en) 2013-10-31 2020-05-08 Resolve Therapeutics Llc Nuclease-albumin fusions and therapeutic methods

Also Published As

Publication number Publication date
FR7058M (en) 1969-06-23
BE705035A (en) 1968-04-12
GB1136039A (en) 1968-12-11
NL6713800A (en) 1968-04-16
ES345979A1 (en) 1968-12-01
FR1552939A (en) 1969-01-10

Similar Documents

Publication Publication Date Title
CH487916A (en) Process for the preparation of 2-cycloalkylamino-oxazolines
CH484108A (en) Process for the preparation of pyrrylaminoethanols
CH490294A (en) Process for the preparation of 3-methylpentenes
CH485731A (en) Process for the preparation of 3-amino-4-carboxamidopyrazole
CH479626A (en) Process for the preparation of organooxysilanes
CH484016A (en) Process for the preparation of hydrindacenes
CH491064A (en) Process for the preparation of diacetone-L-sorbose
CH487177A (en) Process for the preparation of thiaimidazolidines
CH484155A (en) Process for the preparation of 6-amino-uracil-5-carboxamide-N-sulfonamides
CH491857A (en) Process for the preparation of phenoxyaminoalkanols
AT275037B (en) Process for the manufacture of agents for inhibiting immune reactions
CH490358A (en) Process for the preparation of 17a-ethynyl-17B-hydroxysteroids
CH472381A (en) Process for the preparation of monohalogenoazeto-azetamides
AT277957B (en) Process for the preparation of alkenones
CH490377A (en) Process for the preparation of aminohydrins
CH495333A (en) Process for the preparation of Trihalogenäthylglycinaten
CH477470A (en) Process for the preparation of ribofuranosides
CH487860A (en) Process for the preparation of arylsulfonylsemicarbazides
CH509249A (en) Process for the preparation of 3-aminoalkyl-3-arylindanols-1
CH506556A (en) Process for the preparation of quinolylmethylpenicillins
CH480435A (en) Process for the preparation of N-demethyl-N-ethyllincomycin C
AT276763B (en) Process for the preparation of polyacyloxamidrazones
AT273165B (en) Process for the preparation of diphenylsilanediols
AT269873B (en) Process for the preparation of 2-nitroimidazoles
AT274780B (en) Process for the preparation of 1-acylaminoadamantanes